295 related articles for article (PubMed ID: 32745632)
21. Association of blood manganese, selenium with steatosis, fibrosis in the National Health and Nutrition Examination Survey, 2017-18.
Spaur M; Nigra AE; Sanchez TR; Navas-Acien A; Lazo M; Wu HC
Environ Res; 2022 Oct; 213():113647. PubMed ID: 35691383
[TBL] [Abstract][Full Text] [Related]
22. Daily Aspirin Use Associated With Reduced Risk For Fibrosis Progression In Patients With Nonalcoholic Fatty Liver Disease.
Simon TG; Henson J; Osganian S; Masia R; Chan AT; Chung RT; Corey KE
Clin Gastroenterol Hepatol; 2019 Dec; 17(13):2776-2784.e4. PubMed ID: 31077838
[TBL] [Abstract][Full Text] [Related]
23. Noninvasive Serum Fibrosis Markers are Associated with Coronary Artery Calcification in Patients with Nonalcoholic Fatty Liver Disease.
Song DS; Chang UI; Kang SG; Song SW; Yang JM
Gut Liver; 2019 Nov; 13(6):658-668. PubMed ID: 30970434
[TBL] [Abstract][Full Text] [Related]
24. Association between klotho and non-alcoholic fatty liver disease and liver fibrosis based on the NHANES 2007-2016.
Chi Z; Teng Y; Liu Y; Gao L; Yang J; Zhang Z
Ann Hepatol; 2023; 28(5):101125. PubMed ID: 37286168
[TBL] [Abstract][Full Text] [Related]
25. Analysis of the mediating role of BMI in associations of different folate forms with hepatic steatosis and liver fibrosis in adolescents in the USA: results from the NHANES 2017-2018.
Wen J; Fei Y; Yuan L; Li K; Xu Q; Cao X; Su J; Zhu Y; Zhang Z
Front Endocrinol (Lausanne); 2023; 14():1273580. PubMed ID: 38116318
[TBL] [Abstract][Full Text] [Related]
26. The Utility of Noninvasive Scores in Assessing the Prevalence of Nonalcoholic Fatty Liver Disease and Advanced Fibrosis in Type 2 Diabetic Patients.
Singh A; Le P; Peerzada MM; Lopez R; Alkhouri N
J Clin Gastroenterol; 2018 Mar; 52(3):268-272. PubMed ID: 28787358
[TBL] [Abstract][Full Text] [Related]
27. Associations between sarcopenia and nonalcoholic fatty liver disease and advanced fibrosis in the USA.
Wijarnpreecha K; Kim D; Raymond P; Scribani M; Ahmed A
Eur J Gastroenterol Hepatol; 2019 Sep; 31(9):1121-1128. PubMed ID: 30888971
[TBL] [Abstract][Full Text] [Related]
28. Visceral-to-Subcutaneous Abdominal Fat Ratio Is Associated with Nonalcoholic Fatty Liver Disease and Liver Fibrosis.
Jung CH; Rhee EJ; Kwon H; Chang Y; Ryu S; Lee WY
Endocrinol Metab (Seoul); 2020 Mar; 35(1):165-176. PubMed ID: 32207277
[TBL] [Abstract][Full Text] [Related]
29. Risk factors for non-alcoholic fatty liver disease-associated hepatic fibrosis in type 2 diabetes patients.
Mansour A; Mohajeri-Tehrani MR; Samadi M; Gerami H; Qorbani M; Bellissimo N; Poustchi H; Hekmatdoost A
Acta Diabetol; 2019 Nov; 56(11):1199-1207. PubMed ID: 31197470
[TBL] [Abstract][Full Text] [Related]
30. Physical activity and diet quality in relation to non-alcoholic fatty liver disease: A cross-sectional study in a representative sample of U.S. adults using NHANES 2017-2018.
Heredia NI; Zhang X; Balakrishnan M; Daniel CR; Hwang JP; McNeill LH; Thrift AP
Prev Med; 2022 Jan; 154():106903. PubMed ID: 34861339
[TBL] [Abstract][Full Text] [Related]
31. The utility of noninvasive scores in assessing the prevalence of nonalcoholic fatty liver disease and advanced fibrosis in type 1 diabetic patients.
Singh A; Le P; Lopez R; Alkhouri N
Hepatol Int; 2018 Jan; 12(1):37-43. PubMed ID: 29318450
[TBL] [Abstract][Full Text] [Related]
32. Development and Validation of Hepamet Fibrosis Scoring System-A Simple, Noninvasive Test to Identify Patients With Nonalcoholic Fatty Liver Disease With Advanced Fibrosis.
Ampuero J; Pais R; Aller R; Gallego-Durán R; Crespo J; García-Monzón C; Boursier J; Vilar E; Petta S; Zheng MH; Escudero D; Calleja JL; Aspichueta P; Diago M; Rosales JM; Caballería J; Gómez-Camarero J; Lo Iacono O; Benlloch S; Albillos A; Turnes J; Banales JM; Ratziu V; Romero-Gómez M;
Clin Gastroenterol Hepatol; 2020 Jan; 18(1):216-225.e5. PubMed ID: 31195161
[TBL] [Abstract][Full Text] [Related]
33. Combination of PNPLA3 and TLL1 polymorphism can predict advanced fibrosis in Japanese patients with nonalcoholic fatty liver disease.
Seko Y; Yamaguchi K; Mizuno N; Okuda K; Takemura M; Taketani H; Hara T; Umemura A; Nishikawa T; Moriguchi M; Yasui K; Kamaguchi M; Nishioji K; Mochizuki N; Kobayashi M; Mori K; Tanaka S; Matsuura K; Tanaka Y; Itoh Y
J Gastroenterol; 2018 Mar; 53(3):438-448. PubMed ID: 28744823
[TBL] [Abstract][Full Text] [Related]
34. Prevalence of High and Moderate Risk Nonalcoholic Fatty Liver Disease Among Adults in the United States, 1999-2016.
Golabi P; Paik JM; Harring M; Younossi E; Kabbara K; Younossi ZM
Clin Gastroenterol Hepatol; 2022 Dec; 20(12):2838-2847.e7. PubMed ID: 34929391
[TBL] [Abstract][Full Text] [Related]
35. Predictors of advanced fibrosis in elderly patients with biopsy-confirmed nonalcoholic fatty liver disease: the GOASIA study.
Pitisuttithum P; Chan WK; Piyachaturawat P; Imajo K; Nakajima A; Seki Y; Kasama K; Kakizaki S; Fan JG; Song MJ; Yoon SK; Dan YY; Lesmana L; Ho KY; Goh KL; Wong VWS; Treeprasertsuk S
BMC Gastroenterol; 2020 Apr; 20(1):88. PubMed ID: 32252638
[TBL] [Abstract][Full Text] [Related]
36. Association between frailty and hepatic fibrosis in NAFLD among middle-aged and older adults: results from NHANES 2017-2020.
Atabieke F; Li XJ; Aierken A; Li J; Zhang Y; Aizezi Y; Gao HL; Zhang ZQ
Front Public Health; 2024; 12():1330221. PubMed ID: 38389936
[TBL] [Abstract][Full Text] [Related]
37. The severity of NAFLD is associated with the risk of urolithiasis.
Qin S; Wang J; Zhou C; Zhang Y; Xu Y; Wang X; Wang S
Br J Biomed Sci; 2019 Apr; 76(2):53-58. PubMed ID: 30430908
[TBL] [Abstract][Full Text] [Related]
38. Associations of different serum folate forms with indices of nonalcoholic fatty liver disease and advanced fibrosis.
Yang S; Ye Z; Liu M; Zhang Y; Wu Q; Zhou C; Zhang Z; He P; Zhang Y; Li H; Liu C; Qin X
Obes Res Clin Pract; 2023; 17(1):58-65. PubMed ID: 36746711
[TBL] [Abstract][Full Text] [Related]
39. Serum immunoreactive collagen IV detected by monoclonal antibodies as a marker of severe fibrosis in patients with non-alcoholic fatty liver disease.
Aida Y; Abe H; Tomita Y; Nagano T; Seki N; Sugita T; Itagaki M; Ishiguro H; Sutoh S; Aizawa Y
J Gastrointestin Liver Dis; 2015 Mar; 24(1):61-8. PubMed ID: 25822435
[TBL] [Abstract][Full Text] [Related]
40. Non-alcoholic fatty liver disease and 30-day all-cause mortality in adult patients with community-acquired pneumonia.
Nseir WB; Mograbi JM; Amara AE; Abu Elheja OH; Mahamid MN
QJM; 2019 Feb; 112(2):95-99. PubMed ID: 30325458
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
